The life and times of the estrogen receptors: An interim report

Climacteric

Volumn 4, Issue 3, 2001, Pages 194-202

  Albertazzi, P ^a   Purdie, D W ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Estrogen receptor A and B

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MEMBRANE RECEPTOR;

BREAST DEVELOPMENT; ESTROGEN THERAPY; GENE EXPRESSION; OVARY DEVELOPMENT; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; TISSUE DISTRIBUTION; UTERUS GROWTH;

EID: 0034820753     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.4.3.194.202     Document Type: Review

References (57)

1. Non genomic action of steroid hormones in reproductive tissues
2. Estrogens hits the surface
3. The molecular and neuroanatomical basis for estrogen effects in the central nervous system
4. Estrogen action in the central nervous system
5. Basic guide to the mechanism of oestrogen action
6. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
7. Sequence and expression of human estrogen receptor complementary DNA
8. Estrogen receptor variants in normal human mammary tissue
9. Estrogen receptors variants and mutations
10. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
11. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
12. Cloning of a novel receptor expressed in rat prostate and ovary
13. Estrogen receptor β - A new dimension in estrogen mechanism of action. Review
14. Structural insight into the mode of action of a pure antiestrogen
15. Identification of two transactivation domains in the mouse estrogen receptor
16. Activation of the estrogen receptor through phosphoryilation by mitogen-activated protein-kinase
17. Human estrogen-receptor transactional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
18. The hormone-binding domains of the oestrogen and glucocorticoid receptor contain an inducible transcription activation function
19. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal region of a steroid nuclear receptor
20. Evolution of distinct DNA-binding specificities within the nuclear receptor family of transcription factors
21. Human estrogen receptor β-gene structure, chromosomal localisation, and expression pattern
22. Nuclear receptor coactivators and corepressors
23. Nuclear receptor coagulator: Cellular and molecular biology
24. Nuclear factor RIP 140 modulates transcriptional activation by the estrogen receptor
25. TIF, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
26. Sequence and characterisation of a coactivator for the steroid hormone receptor superfamily
27. Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras
28. Novel steroidal pure antiestrogens
29. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
30. Identification of conserved region required for hormone dependent transcriptional activation by steroid hormone binding receptors
31. Structure and specificity of nuclear receptor-coactivator interactions
32. Molecular basis of agonism and antagonism in the oestrogen receptor
33. Differential ligand activation of oestrogen receptor ERα and β at AP1 sites
34. Generation and reproductive phenotypes of mice lacking estrogen receptor beta
35. Postnatal sex reversal of the ovary in mice lacking estrogen receptor αβ
36. Estrogen receptor null mice: What have we learned and where will they lead us?
37. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor beta (ER-beta) messenger ribonucleic acid in the wild-type and ER alpha-knockout mouse
38. Estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) mRNAs in normal ovaries, ovarian serous cyst-adenocarcinoma and ovarian cancer cell lines: Down regulation of ERβ in neoplastic tissues
39. Expression of oestrogen recepror-α and - ER-β mRNA in corpus luteum of human subjects
40. Tissue compartment-specific estrogen receptor-α participation in the mouse uterine epitheleial secretory response
41. Immunocytochemical localisation of estrogen receptors α and β in the human reproductive organs
42. Identification of wild-type and exon 5 deletion variants of estrogen receptor β in normal human mammary gland
43. Mammary gland development and tumorigenesis in estrogen receptor knockout mice
44. Low oestrogen receptor α expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet
45. Steroid hormone receptor expression and action on bone
46. The estrogen receptor is developmentally up-regulated during osteoblast differentiation
47. Estrogen receptor-α is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression
48. Differential expression of estrogen receptor α and β mRNA during differentiation of human osteoblast SV-HFO cells
49. Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction
50. The human forebrain has discrete estrogen receptor alpha messenger RNA expression: High levels in the amygdaloid complex
51. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury
52. Human vascular smooth muscle cells contain functional estrogen receptor
53. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta
54. Oestrogen receptors in macrophages
55. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcript similar to those of normal cell
56. Estrogen receptor α is a major mediator of 17β-estradiol's atheroprotective effects on lesion size in Apo E -0- mice
57. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptor α and β